Multicenter randomized controlled trial of neoadjuvant chemoradiotherapy alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic adenocarcinoma.
Matthew H G KatzGina R PetroniTodd BauerMatthew J ReilleyBrian M WolpinChee-Chee StuckyTanios S Bekaii-SaabRawad EliasNipun MerchantAndressa Dias CostaPatrick LenehanVictoire Cardot-RuffinoScott RodigKathleen PfaffStephanie K DouganJonathan Andrew NowakGauri R VaradhacharyCraig L SlingluffOsama RahmaPublished in: Journal for immunotherapy of cancer (2023)
TILs was observed.